Literature DB >> 808540

Arrangement of human erythrocyte membrane proteins.

E Reichstein, R Blostein.   

Abstract

The orientation of human erythrocyte membrane protein was examined by enzymic iodination using lactoperoxidase with the glucose-oxidase system for generating peroxide, followed by proteolytic digestion. The outer surface of intact cells was labeled with 125I and the cytoplasmic surface of either resealed ghosts containing lactoperoxidase or of inside-out vesicles was labeled with 131I. Following iodination, the outer surface (resealed ghosts) or the cytoplasmic surface (outer surface of inside-out vesicles) was digested with trypsin, chymotrypsin, or pronase. Sodium dodecyl sulfate gel electrophoresis of the isolated membranes revealed three major and several minor peaks of radioactivity. Their surface orientation, defined within the limits of the specificity of the probes used, was as follows: the three major peaks consist of: (a) a 90,000 to 100,000 molecular weight component labeled on both surfaces; its proteolytic digestion profile indicated that it spans the membrane in an asymmetric manner and that it is composed of more than one peptide; (b) the major red cell membrane glycoprotein (apparent molecular weight 60,000) which is labeled and digested at only the outer surface; and (c) peptide(s) of high molecular weight (approximately 200,000), labeled and digested at only the cytoplasmic surface. The minor components include a glycoprotein of approximately 25,000 (apparent molecular weight) accessible to both surfaces and peptides of 60,000 to 70,000, 45,000, and 20,000 molecular weight labeled only on the inner surface.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Identification of differences between the surface proteins and glycoproteins of normal mouse (Balb/c) and human erythrocytes.

Authors:  R J Howard; P M Smith; G F Mitchell
Journal:  J Membr Biol       Date:  1979-08       Impact factor: 1.843

2.  Contact patterns in concanavalin A agglutinated erythrocytes.

Authors:  H Darmani; W T Coakley
Journal:  Cell Biophys       Date:  1991-02

3.  Ionic-strength-dependent changes in the structure of the major protein of the human erythrocyte membrane.

Authors:  R E Jenkins; M J Tanner
Journal:  Biochem J       Date:  1977-01-01       Impact factor: 3.857

Review 4.  Oligomeric structure and the anion transport function of human erythrocyte band 3 protein.

Authors:  M L Jennings
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

5.  Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells.

Authors:  Alexander Luginbühl; Milica Nikolic; Hans Peter Beck; Mats Wahlgren; Hans U Lutz
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

6.  Phosphate transport in human red blood cells: concentration dependence and pH dependence of the unidirectional phosphate flux at equilibrium conditions.

Authors:  K F Schnell; E Besl; R von der Mosel
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

7.  Glycophorin A interferes in the agglutination of human erythrocytes by concanavalin A. Explanation of the requirement for enzymic predigestion.

Authors:  S M Gokhale; N G Mehta
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

8.  Loss of the transferrin receptor during the maturation of sheep reticulocytes in vitro. An immunological approach.

Authors:  B T Pan; R Blostein; R M Johnstone
Journal:  Biochem J       Date:  1983-01-15       Impact factor: 3.857

9.  The structure of the major protein of the human erythrocyte membrane. Characterization of the intact protein and major fragments.

Authors:  R E Jenkins; J A Tanner
Journal:  Biochem J       Date:  1977-01-01       Impact factor: 3.857

10.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.